Aflunov

Aflunov is a vaccine designed to protect against the H5N1 influenza strain. It is administered intramuscularly and is manufactured by Seqirus S.R.L. in the EU. This vaccine is intended for use in preventing influenza caused by the H5N1 virus.

Aflunov is used for the prevention of influenza caused by the H5N1 virus. This vaccine is specifically formulated to target the A/Turkey/Turkey/1/05 (H5N1)-Like Strain (NIBRG-23). It is administered intramuscularly and is intended for use in individuals who are at risk of exposure to this particular strain of influenza.

Common effects of Aflunov may include mild soreness, redness, or swelling at the injection site. Some individuals may experience temporary discomfort or mild fever. These effects are generally mild and short-lived.

Aflunov should be stored and handled according to the manufacturer's instructions to maintain its efficacy. It is important to inform healthcare providers about any allergies or medical conditions before receiving this vaccine. Always follow the advice of a healthcare professional regarding the administration of Aflunov.

Aflunov may interact with certain medications or other vaccines. It is important to discuss any current medications or recent vaccinations with a healthcare provider before receiving Aflunov. Additionally, alcohol or other substances may affect the body's response to the vaccine.